EP 0509761 A1 19921021 - Transdermal composition containing selegiline.
Title (en)
Transdermal composition containing selegiline.
Title (de)
Selegilin enthaltendes transdermales Arzneimittel.
Title (fr)
Composition transdermique à base de sélégiline.
Publication
Application
Priority
HU 122991 A 19910415
Abstract (en)
The invention concerns an anhydrous transdermal preparation comprising in a 20-100% lyotropic liquid crystalline arrangement: 5-15 w.% of optically active or racemic N-methyl-N-(phenyl-2-propyl)-2-propynylamine or N-methyl-N-(1-(4-fluoro-phenyl)-2-propyl)-2-propynylamine or their therapeutically acceptable salts, 40-70 w.% of liquid polyoxyethyleneglycol, 10-20 w.% of solid polyoxyethyleneglycol, 2-30 w.% of a nonionic surface active agent, 2-20 w.% of propyleneglycol, if desired 0.5-2 w.% of a polymer the a value of which is > 0.6, and if desired other auxiliary agents.
IPC 1-7
IPC 8 full level
A61K 9/70 (2006.01); A61K 9/06 (2006.01); A61K 9/127 (2006.01); A61K 31/13 (2006.01); A61K 31/135 (2006.01); A61K 31/75 (2006.01); A61K 47/10 (2006.01); A61K 47/34 (2006.01); A61L 15/16 (2006.01); A61M 37/00 (2006.01); A61P 17/00 (2006.01); C08L 71/02 (2006.01)
CPC (source: EP KR US)
A61K 9/1274 (2013.01 - EP US); A61K 9/70 (2013.01 - KR); A61K 31/135 (2013.01 - EP KR US); A61P 17/00 (2018.01 - EP)
Citation (search report)
- [AD] WO 8909051 A1 19891005 - SANDOZ AG [AT], et al
- [AD] EP 0406488 A1 19910109 - SOMERSET PHARMACEUTICALS INC [US]
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IT LI LU NL PT SE
DOCDB simple family (publication)
EP 0509761 A1 19921021; EP 0509761 B1 19960911; AT E142486 T1 19960915; AU 1484992 A 19921022; AU 648886 B2 19940505; BG 61637 B1 19980227; CA 2065134 A1 19921016; CS 111092 A3 19921118; CZ 281261 B6 19960717; DE 69213536 D1 19961017; DE 69213536 T2 19970320; DK 0509761 T3 19970217; EC SP920873 A 19940202; EE 03038 B1 19971015; ES 2092031 T3 19961116; FI 101677 B1 19980814; FI 101677 B 19980814; FI 921690 A0 19920415; FI 921690 A 19921016; GR 3021505 T3 19970131; HK 1003977 A1 19981113; HR P920570 A2 19940831; HU 209605 B 19940928; HU 211544 A9 19951228; HU 911229 D0 19911028; HU T63560 A 19930928; IE 921019 A1 19921021; IL 101487 A0 19921230; IL 101487 A 19960119; JP 2547151 B2 19961023; JP H06128152 A 19940510; KR 920019341 A 19921119; KR 950008766 B1 19950808; LT 3044 B 19940925; LT IP176 A 19940325; LV 10044 A 19940510; LV 10044 B 19950220; MX 9201732 A 19921001; NO 303903 B1 19980921; NO 921481 D0 19920414; NO 921481 L 19921016; NZ 242335 A 19940627; PH 29992 A 19961029; PL 173234 B1 19980227; PL 294240 A1 19930920; RO 109603 B1 19950428; RU 2088617 C1 19970827; SK 278666 B6 19971210; TW 198690 B 19930121; UA 26892 C2 19991229; US 5380761 A 19950110; YU 38492 A 19950327; YU 48552 B 19981105; ZA 922355 B 19921230
DOCDB simple family (application)
EP 92303341 A 19920414; AT 92303341 T 19920414; AU 1484992 A 19920414; BG 9623292 A 19920414; CA 2065134 A 19920403; CS 111092 A 19920413; DE 69213536 T 19920414; DK 92303341 T 19920414; EC SP920873 A 19921015; EE 9400116 A 19940810; ES 92303341 T 19920414; FI 921690 A 19920415; GR 960402874 T 19961030; HK 98103149 A 19980416; HR P920570 A 19920928; HU 122991 A 19910415; HU 9500215 P 19950616; IE 921019 A 19920330; IL 10148792 A 19920403; JP 9568192 A 19920415; KR 920006147 A 19920413; LT IP176 A 19920828; LV 920007 A 19920409; MX 9201732 A 19920414; NO 921481 A 19920414; NZ 24233592 A 19920413; PH 44168 A 19920407; PL 29424092 A 19920415; RO 92200487 A 19920408; SK 111092 A 19920413; SU 5011496 A 19920414; TW 81103203 A 19920423; UA 93002168 A 19930614; US 14027993 A 19931020; YU 38492 A 19920414; ZA 922355 A 19920331